Day: March 2, 2020

Paris, 2 mars 2020, 8h15AB Science tiendra une web conférence sur le masitinibdans les formes progressives de la sclérose en plaques le vendredi 6 mars 2020AB Science SA (NYSE Euronext – FR0010557264 – AB) tiendra une web conférence le 6 mars 2020 avec les principaux leaders d’opinion de cette maladie afin de discuter des résultats de l’étude de phase 2B/3 du masitinib publiés le 20 février dernier dans la sclérose en plaques progressive primaire (PPMS) et la sclérose en plaques secondairement progressive non-active (nSPMS), et du rôle du masitinib comme possible traitement dans cette indication.Cette web conférence sera animée par 3 principaux leaders d’opinion :Patrick Vermersch, MD, PhD (Université de Lille, France), leader d’opinion européen dans la sclérose en plaques,Robert Fox (Centre Mellen pour la Sclérose en Plaques,...

Paris, 2nd March 2020,Casino, Guichard-Perrachon has been informed by its reference shareholder, Rallye, that on 28 February the Paris Commercial Court approved the safeguard plans for Rallye and its subsidiaries Cobivia, HMB and Alpétrol, as well as for their parent companies Foncière Euris, Finatis and Euris.Casino Group takes due note of the Court’s decisions, which entail financial commitments for these companies from 2023 onwards.Casino Group confirms that it will continue to implement its strategic plan for 2020-2022: further development of the Group’s unique positioning in promising formats (premium, local, e-commerce) and geographical areas; acceleration in new high-growth businesses (energy, data); in financial terms, priority will be given to debt reduction and the generation of recurring cash flow.The only decisions...

  Paris, le 2 mars 2020,La société Casino, Guichard-Perrachon a été informée par son actionnaire de référence, Rallye, que le Tribunal de commerce de Paris a arrêté le 28 février les plans de sauvegarde de Rallye et ses filiales Cobivia, HMB et Alpétrol, ainsi que de leurs maisons-mères les sociétés Foncière Euris, Finatis et Euris.Le groupe Casino prend bonne note des décisions du Tribunal, qui emportent pour ces sociétés des engagements financiers à partir de 2023.Le groupe Casino confirme poursuivre l’exécution de son plan stratégique 2020-2022 : accentuation du positionnement unique du Groupe sur les formats (premium, proximité, e-commerce) et géographies porteurs ; accélération sur les nouveaux métiers à forte croissance (énergie, data) ; en matière financière, priorité au désendettement et à la génération de cash-flows récurrents.Les...

Mandatory Notification of Trades – Attachment Correction ASKER, NORWAY (28 February 2020) – In February 2019, TGS implemented an Employee Share Purchase Plan (ESPP) pursuant to which eligible employees are allowed to purchase TGS common shares at a discount through payroll deductions.  The ESPP operates in six-month periods, and at the end of each period, employees have the option to purchase stock at a 15% discount to the market price at the time of purchase.  The plan sets a maximum purchase of 100 shares per employee per six-month period.  On February 24, 2020 the following primary insiders purchased shares as participants in the ESPP.  The schedule attached reflects the holdings of the primary insiders following the purchase.   —- Katja Akentieva — 100 shares—- Fredrik Amundsen — 100 shares—-...

Correction: the information in the table of the notice was corrected.During the twelve months of 2019, AUGA group, AB and its subsidiaries’ (hereinafter – the Group) results showed improvement in all the business segments.Sales revenue amounted to EUR 71.13 million, demonstrating an  increase of 30% compared to the same period in 2018, when it totalled EUR 54.75 million.The Group’s gross profit for year of 2019 amounted to EUR 11.92 million and showed  186% growth or was EUR 6.81 million higher, compared to the same period in 2018 (gross profit for year 2018 was EUR 3.66 million).Per twelve months period of 2019, Group’s net loss amounted to EUR 2.44 compared to net loss of EUR 5.98 million a year earlier. It should be noted that the financial results of both 2019 and 2018 were highly affected  by several one-off events and changes...

 Patikslinimas: Patikslinti lentelės duomenys pranešime.Per 2019 m. „AUGA group“, AB ir jos dukterinių bendrovių (toliau – Grupė) rezultatai  ženkliai pagerėjo visuose Grupės veiklos segmentuose.Bendrosios pardavimo pajamos siekė 71,13 mln. Eur ir buvo 30% didesnės nei 2018 m. atitinkamą laikotarpį, kai jos sudarė 54,75 mln. Eur.2019 m. Grupės bendrasis pelnas sudarė 11,92 mln. Eur ir buvo 186% arba 6,81 mln. Eur didesnis nei tuo pačiu laikotarpiu pernai (2018 m. bendrasis pelnas – 3,66 mln. Eur).Per 2019 m. Grupė patyrė 2,44 mln. Eur grynojo nuostolio palyginus su 5,98 mln. Eur nuostolių metais prieš tai. Būtina pažymėti, kad tiek šių metų rezultatams, tiek praėjusių metų atitinkamo laikotarpio rezultatams reikšmingą įtaką turėjo įvairūs vienkartiniai veiksniai bei apskaitos politikos pokyčiai, su kuriais galima susipažinti  pateikiamų...

Investors House OyjSisäpiiritietoJulkaistavissa 2.3.2020 klo 8.25INVESTORS HOUSE ALOITTAA OMIEN OSAKKEIDEN HANKINNAN – YKSI KEINO LUODA OMISTAJA-ARVOAInvestors Housen hallitus on päättänyt hankkia omia osakkeita enintään 100 000 kappaletta, mikä on enintään noin 1,6 % koko osakekannasta. Osakkeet hankitaan Nasdaq Helsingin järjestämässä julkisessa kaupankäynnissä hankintahetken markkinahintaan.’’Näemme omien osakkeiden hankinnan yhtenä pragmaattisena keinona luoda omistaja-arvoa’’, sanoo Investors Housen toimitusjohtaja Petri Roininen.Omien osakkeiden hankinta aloitetaan aikaisintaan 3.3.2020 ja lopetetaan 30.4.2020 tai kun määrä on tullut täyteen.Investors Housella on yhteensä 6.182.287 osaketta, joista ulkona 6.012.811 osaketta ja yhtiön omistuksessa 169.476 osaketta. Ylimääräinen yhtiökokous valtuutti 24.1.2019 hallituksen päättämään...

MONT-SAINT-GUIBERT, Belgium, March 02, 2020 (GLOBE NEWSWIRE) — Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that Stephen Rubino, Ph.D., has been appointed Chief Business Officer. Dr. Rubino has more than 25 years of strong commercial and strategic development experience in the pharmaceutical and biotechnology industry, including 17 years at Novartis. He will serve on the executive leadership team and will lead business and corporate development for Celyad.“We are excited to have Stephen join Celyad as we continue to grow our executive team’s presence in the U.S. while broadening our global perspective of the industry,” said Filippo Petti, Chief Executive Officer of Celyad. “Stephen has tremendous business...

Amsterdam, March 2, 2020 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, today announced the ten startups selected for the second wave of its City of 2030 accelerator, powered by Techstars. This is year two of the program, which is aimed at identifying and developing innovative startups to transform the natural and built environment. The startups featured are focused on developing ideas around urban planning, resiliency, sustainability, new mobility, and logistic services. The core technology and products of the various startups complement Arcadis’ existing business and strategic vision. The companies will work with the program team during a three-month accelerator program in office space provided by Arcadis in Amsterdam, and take part in a Demo Day to showcase...

On February 28, 2020, the Supervisory Board of EfTEN Real Estate Fund III AS decided to extend the term of office of the members of the Management Board. According to the decision of the Supervisory Board, Viljar Arakas and Tõnu Uustalu shall continue as members of the Management Board and the terms of office were extended for another 5-year term as of 7 May 2020.Viljar ArakasMember of the Management BoardPhone 655 9515E-mail: viljar.arakas@eften.ee